Evidence map›Paper›PMID 36238249›Full record

ArticleFrontiers in public health2022

Rhein inhibits

Xueying Yu, Qingqing Xu, Wentao Chen, Zhida Mai, Lijun Mo, Xin Su, Jiangli Ou, Yinyuan Lan, Heping Zheng, Yaohua Xue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. A Rhein-Based Derivative TargetsAntibiotics (Basel, Switzerland) · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xueying YuDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Qingqing XuDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Wentao ChenDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Zhida MaiDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Lijun MoDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Xin SuDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Jiangli OuDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Yinyuan LanDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Heping ZhengDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Yaohua XueDepartment of Clinical Laboratory, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global incidence of genital

Indexed as

Chlamydia InfectionsChlamydia trachomatisAnthraquinonesAnti-Bacterial AgentsAzithromycinHumansAnthraquinonesAnti-Bacterial AgentsAzithromycinantibacterial activityazithromycinChlamydia trachomatishost-directed therapyin vivorhein

Identifiers

PMID36238249
PMCPMC9552556
OpenAlexW4297236014

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.